Cargando…

Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone

Antipsychotic-induced agranulocytosis is a significant side effect that is known to occur with most of the antipsychotic medications. It usually resolves once the medications are stopped and patients are able to be switched over to another anti-psychotic medication. Lurasidone has not been reported...

Descripción completa

Detalles Bibliográficos
Autor principal: Sood, Shabnam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678486/
https://www.ncbi.nlm.nih.gov/pubmed/29073755
http://dx.doi.org/10.9758/cpn.2017.15.4.413
_version_ 1783277445032443904
author Sood, Shabnam
author_facet Sood, Shabnam
author_sort Sood, Shabnam
collection PubMed
description Antipsychotic-induced agranulocytosis is a significant side effect that is known to occur with most of the antipsychotic medications. It usually resolves once the medications are stopped and patients are able to be switched over to another anti-psychotic medication. Lurasidone has not been reported to cause leukopenia and neutropenia. This case report is of a patient with a past history of risperidone induced-aganulocytosis developing dose related leukopenia and neutropenia with lurasidone.
format Online
Article
Text
id pubmed-5678486
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Korean College of Neuropsychopharmacology
record_format MEDLINE/PubMed
spelling pubmed-56784862017-11-15 Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone Sood, Shabnam Clin Psychopharmacol Neurosci Case Report Antipsychotic-induced agranulocytosis is a significant side effect that is known to occur with most of the antipsychotic medications. It usually resolves once the medications are stopped and patients are able to be switched over to another anti-psychotic medication. Lurasidone has not been reported to cause leukopenia and neutropenia. This case report is of a patient with a past history of risperidone induced-aganulocytosis developing dose related leukopenia and neutropenia with lurasidone. Korean College of Neuropsychopharmacology 2017-11 2017-11-30 /pmc/articles/PMC5678486/ /pubmed/29073755 http://dx.doi.org/10.9758/cpn.2017.15.4.413 Text en Copyright © 2017, Korean College of Neuropsychopharmacology This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Sood, Shabnam
Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone
title Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone
title_full Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone
title_fullStr Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone
title_full_unstemmed Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone
title_short Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone
title_sort neutropenia with multiple antipsychotics including dose dependent neutropenia with lurasidone
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678486/
https://www.ncbi.nlm.nih.gov/pubmed/29073755
http://dx.doi.org/10.9758/cpn.2017.15.4.413
work_keys_str_mv AT soodshabnam neutropeniawithmultipleantipsychoticsincludingdosedependentneutropeniawithlurasidone